Nonalcoholic steatohepatitis/metabolic dysfunction-associated steatohepatitis emerging market: Preparing managed care for early intervention, equitable access, and integrating the patient perspective.

MLA

Flavin, Bridget. “Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis Emerging Market: Preparing Managed Care for Early Intervention, Equitable Access, and Integrating the Patient Perspective.” Journal of Managed Care & Specialty Pharmacy, vol. 30, no. 9–a Suppl, Sept. 2024, pp. S1–13. EBSCOhost, https://doi.org/10.18553/jmcp.2024.30.9-a.s1.

APA

Flavin, B. (2024). Nonalcoholic steatohepatitis/metabolic dysfunction-associated steatohepatitis emerging market: Preparing managed care for early intervention, equitable access, and integrating the patient perspective. Journal of Managed Care & Specialty Pharmacy, 30(9–a Suppl), S1–S13. https://doi.org/10.18553/jmcp.2024.30.9-a.s1

Chicago

Flavin, Bridget. 2024. “Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis Emerging Market: Preparing Managed Care for Early Intervention, Equitable Access, and Integrating the Patient Perspective.” Journal of Managed Care & Specialty Pharmacy 30 (9–a Suppl): S1–13. doi:10.18553/jmcp.2024.30.9-a.s1.